Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M.
Cancer Res. 2004 Aug 15;64(16):5617-23.
PMID: 15313899
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M.
Cancer Res. 2008 Mar 15;68(6):1945-52.
PMID: 18339876
doi: 10.1158/0008-5472.CAN-07-5176
Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.\nAjith TA, Jose N, Janardhanan KK.\nJ Exp Clin Cancer Res. 2002 Jun;21(2):213-7.\nPMID: 12148580
Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM.
Clin Cancer Res. 2004 Sep 1;10(17):5930-9.
PMID: 15355926
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer.
Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A.
Clin Cancer Res. 2006 Jul 1;12(13):4018-26.
PMID: 16818701
B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver
Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer
Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Anti-aromatase activity of phytochemicals in white button mushrooms (Agaricus bisporus).
Chen S, Oh SR, Phung S, Hur G, Ye JJ, Kwok SL, Shrode GE, Belury M, Adams LS, Williams D.
Cancer Res. 2006 Dec 15;66(24):12026-34.
PMID: 17178902
doi: 10.1158/0008-5472.CAN-06-2206
Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y.
Anticancer Res. 2006 Mar-Apr;26(2A):1113-34. Review.
PMID: 16619514
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Nieswandt B, Hafner M, Echtenacher B, Männel DN.
Cancer Res. 1999 Mar 15;59(6):1295-300.
PMID: 10096562
Selenium and immunocompetence in patients with head and neck cancer.
Kiremidjian-Schumacher L, Roy M, Glickman R, Schneider K, Rothstein S, Cooper J, Hochster H, Kim M, Newman R.
Biol Trace Elem Res. 2000 Feb;73(2):97-111.
PMID: 11049203
DOI: 10.1385/BTER:73:2:97
An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day.
Grant WB, Garland CF, Gorham ED.
Recent Results Cancer Res. 2007;174:225-34. Review.
PMID: 17302200
Meta-analysis of vitamin D, calcium and the prevention of breast cancer.
Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H.
Breast Cancer Res Treat. 2009 Oct 23. [Epub ahead of print]
PMID: 19851861
These results provide strong evidence that vitamin D and calcium have a chemopreventive effect against breast cancer.
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.\nHeaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O'Connor OA.\nCancer Res. 2008 Oct 1;68(19):8031-8.\nPMID: 18829561
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M.
Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31.
PMID: 19285265
doi:10.1016/j.beem.2009.02.001
Grant WB, Garland CF, Gorham ED.
An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day.
Recent Results Cancer Res. 2007;174:225-34.
PMID: 17302200 [PubMed - in process]
Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL.
Cancer Res. 2005 Dec 1;65(23):11146-55.
PMID: 16322265
Re-engineering a protein that helps prevent tumours spreading and growing has created a potentially powerful therapy for people with many different types of cancer. In a study published in the first issue of EMBO Molecular Medicine, Canadian researchers modified the tumour inhibiting protein, von Hippel-Lindau (VHL), and demonstrated that it could suppress tumour growth in mice.